These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 7771543)

  • 1. Effects of repetitive vagal stimulation on heart rate and on cardiac vasoactive intestinal polypeptide efflux.
    Hill MR; Wallick DW; Martin PJ; Levy MN
    Am J Physiol; 1995 May; 268(5 Pt 2):H1939-46. PubMed ID: 7771543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vagal release of vasoactive intestinal peptide can promote vagotonic tachycardia in the isolated innervated rat heart.
    Shvilkin A; Danilo P; Chevalier P; Chang F; Cohen IS; Rosen MR
    Cardiovasc Res; 1994 Dec; 28(12):1769-73. PubMed ID: 7867028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasoactive intestinal polypeptide antagonists attenuate vagally induced tachycardia in the anesthetized dog.
    Hill MR; Wallick DW; Mongeon LR; Martin PJ; Levy MN
    Am J Physiol; 1995 Oct; 269(4 Pt 2):H1467-72. PubMed ID: 7485582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency dependence of vasoactive intestinal polypeptide release and vagally induced tachycardia in the canine heart.
    Hill MR; Wallick DW; Martin PJ; Levy MN
    J Auton Nerv Syst; 1993 May; 43(2):117-22. PubMed ID: 8326095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vagal postganglionic origin of vasoactive intestinal polypeptide (VIP) mediating the vagal tachycardia.
    Markos F; Snow HM
    Eur J Appl Physiol; 2006 Nov; 98(4):419-22. PubMed ID: 16896725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vagal nerve stimulation increases right ventricular contraction and relaxation and heart rate.
    Henning RJ; Feliciano L; Coers CM
    Cardiovasc Res; 1996 Nov; 32(5):846-53. PubMed ID: 8944815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vagal-induced tachycardia: release of vasoactive intestinal peptide and peptide HI.
    Anderson FL; Kralios AC; Cluff N; Hanson GR
    Am J Physiol; 1994 Nov; 267(5 Pt 2):H2019-24. PubMed ID: 7977833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vagal nerve stimulation during muscarinic and beta-adrenergic blockade causes significant coronary artery dilation.
    Feliciano L; Henning RJ
    J Auton Nerv Syst; 1998 Jan; 68(1-2):78-88. PubMed ID: 9531447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vagal stimulation during muscarinic and beta-adrenergic blockade increases atrial contractility and heart rate.
    Henning RJ
    J Auton Nerv Syst; 1992 Sep; 40(2):121-9. PubMed ID: 1464693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An investigation into the presence of a vagal tachycardia and the effect of vasoactive intestinal polypeptide on rat heart rate in vitro.
    Hogan K; Markos F
    Pharmacology; 2006; 76(2):101-4. PubMed ID: 16374072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vagal nerve stimulation releases vasoactive intestinal peptide which significantly increases coronary artery blood flow.
    Feliciano L; Henning RJ
    Cardiovasc Res; 1998 Oct; 40(1):45-55. PubMed ID: 9876316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic atropine administration diminishes the contribution of vasoactive intestinal polypeptide to heart rate regulation.
    Kuncová J; Faitová S; Capouch J; Stengl M; Slavíková J
    Physiol Res; 2008; 57(6):827-837. PubMed ID: 18052688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of vasoactive intestinal polypeptide on heart rate in relation to vagal cardioacceleration in conscious dogs.
    Roossien A; Brunsting JR; Nijmeijer A; Zaagsma J; Zijlstra WG
    Cardiovasc Res; 1997 Feb; 33(2):392-9. PubMed ID: 9074704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasoactive intestinal polypeptide receptor antagonism enhances the vagally induced increase in cardiac interval of the rat atrium in vitro.
    Hogan K; Markos F
    Exp Physiol; 2006 May; 91(3):641-6. PubMed ID: 16527861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time-course and frequency dependence of sympathetic stimulation-evoked inhibition of vagal effects at the sinus node.
    Warner MR
    J Auton Nerv Syst; 1995 Mar; 52(1):23-33. PubMed ID: 7782567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuronally released vasoactive intestinal polypeptide alters atrial electrophysiological properties and may promote atrial fibrillation.
    Xi Y; James Chao ZY; Yan W; Abbasi S; Yin X; Mathuria N; Patel M; Fan C; Sun J; Wu G; Wang S; Elayda M; Gao L; Wehrens XH; Lin SF; Cheng J
    Heart Rhythm; 2015 Jun; 12(6):1352-61. PubMed ID: 25748673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasoactive intestinal polypeptide facilitates atrioventricular nodal conduction and shortens atrial and ventricular refractory periods in conscious and anesthetized dogs.
    Rigel DF; Lathrop DA
    Circ Res; 1990 Dec; 67(6):1323-33. PubMed ID: 2245498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Release of vasoactive intestinal peptide and neuropeptide Y from canine heart.
    Anderson FL; Kralios AC; Reid B; Hanson GR
    Am J Physiol; 1993 Sep; 265(3 Pt 2):H959-65. PubMed ID: 8214133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of vasoactive intestinal peptide on pacemaker location and heart rate in the dog atrium.
    Pintér A; Nadeau R; Dandan N; Pagé PL
    Can J Physiol Pharmacol; 1998 Apr; 76(4):457-62. PubMed ID: 9795756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potentiation of sinus arrhythmia by vasoactive intestinal polypeptide (VIP) in the anaesthetized dog.
    Markos F; Snow HM
    Neuropeptides; 2001; 35(5-6):238-43. PubMed ID: 12030808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.